Slide 1: Conference Call Q1 2025
May 8, 2025 Conference Call Q1 2025 © SUSS
Slide 2: Disclaimer
Investor Presentation Disclaimer This presentation contains forward-looking statements relating to the business. financial performance and earnings of SUSS MicroTec SE and its subsidiaries and associates. Forward-looking statements are based on current plans. estimates. projections and expectations
Slide 3: Agenda
Investor Presentation Agenda 01 Highlights Q1 2025 02 Key Financial Figures Q1 2025 03 Outlook 2025 © SUSS
Slide 4: Highlights Q1 2025
Investor Presentation Agenda 01 Highlights Q1 2025 02 Key Financial Figures Q1 2025 03 Outlook 2025 © SUSS
Slide 5: Solid start to the year, particularly in terms of sales growth
Investor Presentation Solid start to the year, particularly in terms of sales growth Financial Results Q1 2025 88.1 123.2 37.9 16.6 in € million in € million in % in % Order intake Sales Gross profit margin EBIT margin Q1 2025 Q1 2025 Q1 2025 Q1 2025 -10.4% YoY +31.8% YoY -1.2pp YoY +0.7pp YoY © SUS
Slide 6: Key CEO messages
Investor Presentation Key CEO messages Order intake in line with expectations, while sales reached the second-best quarter in the company's history thanks to strong operational execution. Book-to-bill ratio in Q1 amounted to 0.72. Announcement of wide-ranging tariffs by the US government causes gene
Slide 7: Segment Overview Q1 2025
Investor Presentation Segment Overview Q1 2025 Advanced Backend Solutions Photomask Solutions in € million Q1 2025 Q1 2024 in € million Q1 2025 Q1 2024 Order intake 54.3 64.6 Order intake 33.7 33.7 Order book 242.4 294.8 Order book 150.4 162.1 Sales 82.9 56.4 Sales 40.3 37.1 Gross profit 30.4 25.1 G
Slide 8: New production site in Zhubei, Taiwan, officially handed over
Investor Presentation New production site in Zhubei, Taiwan, was officially handed over to us – we are now equipping it for our use. Comparison of our production sites in Taiwan Hsinchu Zhubei • In operation since: 2020 • Planned production start: • One production site + H2 2025 eight sub locations
Slide 9: Key Financial Figures Q1 2025
Investor Presentation Agenda 01 Highlights Q1 2025 02 Key Financial Figures Q1 2025 03 Outlook 2025 © SUSS
Slide 10: Strong sales growth and improved Free Cash Flow generation
Investor Presentation Strong sales growth and improved Free Cash Flow generation in € million Q1 2025 Q1 2024 Change Order intake 88.1 98.3 -10.4% • Order intake below previous year, but not a surprise after record in Q4 2024. Order book as of March 31 392.7 456.9 -14.1% • Very positive sales develo
Slide 11: Positive sales trend continued, EBIT margin improved year on year
Investor Presentation Positive sales trend continued, EBIT margin improved year on year Order intake Sales €88.1m (Q1 2025) €123.2m (Q1 2025) 147.5 150.8 93.5 98.3 93.9 99.3 102.5 84.0 Excellent sales development and 88.1 123.2 solid order intake Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 after exceptional Gross profi
Slide 12: Our two segments with different margin development trends
Investor Presentation Our two segments with different margin development trends Order intake Sales Gross profit margin EBIT margin (Q1 2025) (Q1 2025) (Q1 2025) (Q1 2025) €88.1m €123.2m 37.9% 16.6% Advanced 102.1 105.9 44.5% 43.4% 25.7% 40.7% 40.2% Backend 79.6 82.9 36.7% 64.6 65.8 67.7 72.8 17.7% 1
Slide 13: Order Intake by Segment and Region
Investor Presentation Order Intake by Segment (in € m) and Region (in %) Book-to-bill ratio Order Intake Q1 2025: 0.72 by Region Q1 2025 147.5 139.2 EMEA 14.3% 103.1 98.3 94.8 93.9 America 84.0 88.1 83.4 7.0% Asia/ Pacific Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 78.7% € 420.5m € 423.7m € 88.1m FY 2023 F
Slide 14: Minor change in assets in the normal course of business
Investor Presentation Minor change in assets in the normal course of business Assets in € million 500.9 513.4 1 Negligible change in non-current assets compared to year-end 2024. 58.6 1 59.8 Non-current 2 Inventory up 1.5 percent in the first quarter to assets € 217.1 million, after strong increase
Slide 15: Changes due to net income and tax effects
Investor Presentation Changes due to net income and tax effects Liabilities and equity in € million 500.9 513.4 Equity ratio: Equity ratio: 1 Equity position strengthened by net profit 57.1% 55.9% 2 Non-current liabilities up, driven by a € 4.1m increase in deferred tax liabilities. 279.7 1 292.9 Lo
Slide 16: Outlook 2025
Investor Presentation Agenda 01 Highlights Q1 2025 02 Key Financial Figures Q1 2025 03 Outlook 2025 © SUSS
Slide 17: Q1 sales and order book provide a solid basis for 2025 sales target
Investor Presentation Q1 sales and current order book provide a solid basis for achieving our sales target for 2025 as a whole Sales achieved in the first quarter of 2025 € 123.2 million Order book as of March 31, 2025, of which the majority is expected to be executed in 2025 € 392.7 million © SUSS
Slide 18: We confirm our forecast for the full year 2025
Investor Presentation We confirm our forecast for the full year 2025, but the risk situation has deteriorated due to the current tariff and trade dispute. Guidance 2025 (as of March 27, 2025) Sales Gross profit EBIT margin in € million margin in % in % 470–510 39–41 15–17 Actual 2024: Actual 2024: A
Slide 19: Investor Relations information
Investor Presentation Investor Relations information Conference and Roadshow Calendar Financial Calendar May 21, 2025 May 8, 2025 Chicago Roadshow, hosted by Jefferies Q1 Report 2025 May 22, 2025 June 3, 2025 Berenberg European Conference, New York City Annual General Meeting May 27, 2025 August 7,
Slide 20: Thank you
Thank you Growing Innovation Sven Koepsel VP Investor Relations & Communications Tel.: +49 89 32007-151 E-mail: sven.koepsel@suss.com Florian Mangold Manager Investor Relations Tel.: +49 89 32007-306 E-mail: florian.mangold@suss.com 20